Novel Benzimidazole Derived Imine Ligand and Its Co(III) and Cu(II) Complexes as Anticancer Agents: Chemical Synthesis, DFT Studies, In Vitro and In Vivo Biological Investigations

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 16; no. 1; p. 125
• Main Authors: G, Prakasha, Revanasiddappa, H D, B, Jayalakshmi, T, Prabhakar B, Shivamallu, Chandan, Viswanath, Prashant M, Achar, Raghu Ram, Silina, Ekaterina, Stupin, Victor, Manturova, Natalia, Shati, Ali A, Alfaifi, Mohammad Y, Elbehairi, Serag Eldin I, Armaković, Sanja J, Armaković, Stevan, Kollur, Shiva Prasad
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 13.01.2023; MDPI
• Subjects: antitumor activity; Aqueous solutions; benzimidazole; Cancer; Chemistry; DFT; Investigations; Ligands; Schiff base; Solvents; Schiff base; benzimidazole; DFT; antitumor activity
• ISSN: 1424-8247; 1424-8247
• DOI: 10.3390/ph16010125

The emerging interest in the field of coordination chemistry and their biological applications has created a novel impact in the field of chemical biology. With this motivation, in this work we have synthesized a novel benzimidazole derived imine ligand, 2-((E)-((1H-benzo[d]-2-yl)methylimino)methyl)-4-fluorophenol ( ) and its Co(III) and Cu(II) complexes. The metal complexes ( - ) were synthesized in 2:1 ( : metal ion) and 1:1:1 ( : metal ion: 1,10-phen) ratios. Structural elucidations of all the synthesized compounds were performed using FT-IR, UV-Visible, NMR, Mass spectroscopy and elemental analysis techniques. A combination of first principles calculations and molecular dynamics simulations was applied to computationally investigate the structural, reactive, and spectroscopic properties of the newly synthesized ligand and its complexes with copper and cobalt metal ions. Quantum-mechanical calculations in this study were based on the density functional theory (DFT), while molecular dynamics (MD) simulations were based on the OPLS4 force field. The DFT calculations were used to obtain the reactive and spectroscopic properties of the ligand and its complexes, while molecular dynamics (MD) simulations were used to address the ligand's reactivity with water. Further, the in vitro anti-proliferative activity of the compounds was tested against the A549, Ehrlich-Lettre ascites carcinoma (EAC), SIHA and NIH3T3 cell lines. The biological results depicted that the compound , with molecular formula C H Cl CoFN O exhibited profound anti-proliferative activity against the EAC cell line with a significant IC value of 10 µm when compared to its parent ligand and other remaining metal complexes under study. Various assays of hematological parameters (alkaline phosphate, creatinine, urea, RBC and WBC) were performed, and significant results were obtained from the experiments. Furthermore, the effect of on neovascularization was evaluated by stimulating the angiogenesis with rVEGF , which was compared with non-tumor models. The EAC cells were cultured in vivo and administrated with 50 and 75 mg/kg of two doses and tumor parameters were evaluated.